Your browser doesn't support javascript.
loading
A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.
Michallet, Anne-Sophie; Letestu, Rémi; Le Garff-Tavernier, Magali; Aanei, Carmen; Ticchioni, Michel; Dilhuydy, Marie-Sarah; Subtil, Fabien; Rouille, Valerie; Mahe, Beatrice; Laribi, Kamel; Villemagne, Bruno; Salles, Gilles; Tournilhac, Olivier; Delmer, Alain; Portois, Christelle; Pegourie, Brigitte; Leblond, Veronique; Tomowiak, Cecile; De Guibert, Sophie; Orsini Piocelle, Frederique; Banos, Anne; Carassou, Philippe; Cartron, Guillaume; Fornecker, Luc-Matthieu; Ysebaert, Loic; Dartigeas, Caroline; Truchan-Graczyk, Malgorzata; Vilque, Jean-Pierre; Aurran, Thérèse; Cymbalista, Florence; Lepretre, Stéphane; Levy, Vincent; Nguyen-Khac, Florence; Feugier, Pierre.
Afiliação
  • Michallet AS; Department of Hematology, Centre Léon Bérard, Lyon, France.
  • Letestu R; Department of Hematology Biology, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Le Garff-Tavernier M; Department of Hematology Biology, AP-HP, Pitié Salpêtrière, Paris, France.
  • Aanei C; Department of Hematology Biology, Centre Hospitalier Universitaire (CHU) Saint Etienne, Saint Etienne, France.
  • Ticchioni M; Department of Immunology, CHU Nice, Nice, France.
  • Dilhuydy MS; Department of Hematology, CHU Bordeaux, Bordeaux, France.
  • Subtil F; Service de Biostatistique, Hospices Civils de Lyon, Lyon, France.
  • Rouille V; Laboratoire de Biométrie et Biologie Évolutive, Unité Mixte de Recherche (UMR) 5558, Université Lyon 1, Université de Lyon, Centre National de la Recherche Scientifique (CNRS), Villeurbanne, France.
  • Mahe B; Department of Hematology, CHU Montpellier, Montpellier, France.
  • Laribi K; Department of Hematology, CHU Nantes, Nantes, France.
  • Villemagne B; Department of Clinical Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Salles G; Department of Clinical Hematology, Centre Hospitalier Départemental (CHD) Vendée, La Roche sur Yon, France.
  • Tournilhac O; Department of Hematology, Hospices Civils de Lyon, Lyon, France.
  • Delmer A; Department of Hematology, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Portois C; Department of Hematology, CHU Reims, Reims, France.
  • Pegourie B; Department of Hematology, CHU Saint Etienne, Saint Etienne, France.
  • Leblond V; Department of Hematology, CHU Grenoble, Grenoble, France.
  • Tomowiak C; Department of Hematology, Pitié-Salpêtrière Hospital, Université Paris Sorbonne, AP-HP, Paris, France.
  • De Guibert S; Department of Hematology, CHU Poitiers, Poitiers, France.
  • Orsini Piocelle F; Department of Hematology, CHU Rennes, Rennes, France.
  • Banos A; Department of Clinical Hematology, Centre Hospitalier Annecy Genevois, Annecy Genevois, France.
  • Carassou P; Department of Clinical Hematology, Centre Hospitalier Bayonne, Bayonne, France.
  • Cartron G; Department of Hematology, Centre Hospitalier Régional (CHR) Metz-Thionville, Metz, France.
  • Fornecker LM; Department of Hematology, CHU Montpellier, Montpellier, France.
  • Ysebaert L; Department of Hematology, CHU Strasbourg, Strasbourg, France.
  • Dartigeas C; Department of Hematology, CHU Toulouse, Toulouse, France.
  • Truchan-Graczyk M; Department of Hematology, CHU Tours, Tours, France.
  • Vilque JP; Department of Hematology, CHU Angers, Angers, France.
  • Aurran T; Department of Hematology, CHU Caen, Caen, France.
  • Cymbalista F; Department of Hematology, Institut Paoli Calmettes, Marseille, Marseille, France.
  • Lepretre S; Department of Hematology, Avicenne Hospital, AP-HP, Bobigny, France.
  • Levy V; Department of Hematology, Centre de Lutte Contre le Cancer Centre Henri-Becquerel, Haute Normandie, Rouen, France.
  • Nguyen-Khac F; Unité de Recherche Clinique/Centre de Recherche Clinique, Avicenne Hospital, AP-HP, Bobigny, France; and.
  • Feugier P; Department of Hematology, Pitié-Salpêtrière Hospital, Université Paris Sorbonne, AP-HP, Paris, France.
Blood ; 137(8): 1019-1023, 2021 02 25.
Article em En | MEDLINE | ID: mdl-33167024
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França